Utility of routine nurse assessment of the risk of chemotherapy-induced febrile neutropenia
Evidence-based guidelines recommend that patients at high risk (≥ 20%) for febrile neutropenia (FN) should receive prophylactic colony-stimulating factors (Aapro et al., 2006; Kouroukis et al., 2008; National Comprehensive Cancer Network [NCCN], 2008; Smith et al., 2006). We studied the utility of h...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pappin Communications
2010-04-01
|
| Series: | Canadian Oncology Nursing Journal |
| Online Access: | http://www.canadianoncologynursingjournal.com/index.php/conj/article/view/186/194 |